Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMCITABINE\GEMCITABINE for Pancreatic carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,434 adverse event reports in the FDA FAERS database where GEMCITABINE\GEMCITABINE was used for Pancreatic carcinoma.

Most Reported Side Effects for GEMCITABINE\GEMCITABINE

Side Effect Reports % Deaths Hosp.
Disease progression 951 9.3% 310 84
Thrombocytopenia 939 9.2% 177 299
Neutropenia 907 8.9% 166 239
Anaemia 721 7.1% 149 299
Nausea 603 5.9% 81 303
Malignant neoplasm progression 551 5.4% 157 104
Off label use 542 5.3% 78 209
Death 511 5.0% 511 72
Vomiting 499 4.9% 71 268
Pyrexia 498 4.9% 70 348
Diarrhoea 452 4.4% 74 208
Fatigue 434 4.3% 81 169
Drug ineffective 397 3.9% 102 57
Febrile neutropenia 369 3.6% 102 191
Leukopenia 333 3.3% 43 76

Other Indications for GEMCITABINE\GEMCITABINE

Pancreatic carcinoma metastatic (1,171) Adenocarcinoma pancreas (693) Product used for unknown indication (485) Non-small cell lung cancer (314) Cholangiocarcinoma (292) Ovarian cancer (256) Transitional cell carcinoma (255) Bladder cancer (240) Breast cancer metastatic (229) Diffuse large b-cell lymphoma (209)

Other Drugs Used for Pancreatic carcinoma

PACLITAXEL (3,386) GEMCITABINE (2,706) IRINOTECAN (2,128) OXALIPLATIN (1,941) CAPECITABINE (1,590) FLUOROURACIL (1,556) ERLOTINIB (1,089) PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (722) LEUCOVORIN (700) DURVALUMAB (584)

Related Pages

GEMCITABINE\GEMCITABINE Full Profile All Pancreatic carcinoma Drugs GEMCITABINE\GEMCITABINE Demographics GEMCITABINE\GEMCITABINE Timeline